Research projects
Start of main content
The subarachnoid administration of previously cryopreserved allogenic stromal cells in traumatic spinal lesion
16th national competition for scientific and technical research
Gene and regenerative therapy
Research Centre or Institution : Hospital Universitario Puerta de Hierro Majadahonda. Madrid.
Abstract
Traumatic injury to the spinal cord is a clinical entity that has been known since ancient times. It is highly important in medical as well as in social terms, given that it is one of the most important causes of disability, with very serious consequences for the personal, family and professional life of those who suffer this lesion. Great advances have taken place in the treatment of patients with spinal cord lesions over recent decades, although these centre on the prevention of complications, and although many lines of research are open in this field, there is still no effective treatment that is able to achieve the complete functional recovery of patients with traumatic spinal cord injury, whose deficits are usually permanent and irreversible in most cases. From the studies by Ramón y Cajal in 1914 to date, many publications have centred on the possibilities of regeneration of the spinal cord following traumatic paraplegia, using experimental models that involve enormous technical difficulty due to the need for long-term storage of paraplegic animals (Fraidakiset et al., 2004; Chopp et al., 2000; Hofstetter et al., 2002; Ohta et al., 2004; Parr et al., 2007, Zurita et al., 2004; 2006).
The aim of this project is to evaluate the efficacy of the subarachnoid administration of allogenic cryopreserved mesenchymal stem cells in an experimental model of chronic established traumatic paraplegia in adult pigs (minipigs), comparing the utility of this technique when subarachnoid administration is at a lumbar level or locally, around the zone of the spinal injury. The minipigs will be subjected to a traumatic lesion of the spinal cord at a dorsal level, causing complete and irreversible paraplegia that will be allowed to become chronic before the transplant of the stem cells.
- Activities related
- Projects related
- News related
- Publications related
-
12
Sep
2022
Conferencia online Diseño de materia supramolecular para señalar y emular sistemas vivos ONLINE www.fundacionareces.tv/directo, Monday, 12 September 2022, 19:00 hours
-
26
Sep
2022
Conference Terapia génica y celular avanzada… Más allá de la última frontera Madrid, Monday, 26 September 2022, 19:00 hours
-
9
May
2024
Conference Genes de mosca y genes humanos: una comparación Madrid, Jueves 09 de mayo de 2024, 19:00 horas
- Synthetic nanoparticles as an innovative treatment for sepsis (SPRINT-4-SEPSIS) 2018 Senior Researcher : Antonio Artigas Raventós Research Centre or Institution : Instituto de Investigación e Innovación Parc Taulí (I3PT), Corporación Sanitaria i Universitaria Parc Taulí
- Risk Assesment of Bacterial Sepsis using multiomic and bioinformatics tools: an approach towards the Precision Medicine in Infectious Diseases 2018 Senior Researcher : María Teresa Coque González
- Extracellular vesicles biomarkers for the diagnosis and prognosis of post-surgical septic shock 2018 Senior Researcher : Eduardo Tamayo Gómez Research Centre or Institution : Hospital Clínico Universitario de Valladolid
-
Eric D. Green: “La genómica debe integrarse en la medicina convencional”
Published on 03/12/2021
Stem cells and organoids. Unlocking their potential to understand and treat disease
Febrero 2018 Nature PapersEnd of main content